04/07/2021
3:26 PM | Karyopharm Therapeutics (Filer)
| Form DEF 14A
| |
03/23/2021
6:50 AM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/23/2021
6:48 AM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2021
7:17 PM | Karyopharm Therapeutics (Issuer)
Shah Jatin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2021
7:16 PM | Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2021
7:13 PM | Karyopharm Therapeutics (Issuer)
Lewis Tanya (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2021
7:12 PM | Frenkel Ran (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2021
7:10 PM | DEMAREE JOHN (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2021
7:09 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2021
7:09 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/24/2021
4:22 PM | Karyopharm Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/24/2021
4:00 PM | Karyopharm Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/22/2021
7:12 PM | Karyopharm Therapeutics (Issuer)
Shah Jatin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2021
7:11 PM | Frenkel Ran (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2021
7:10 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2021
7:09 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2021
5:49 PM | Karyopharm Therapeutics (Issuer)
Lewis Tanya (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2021
5:48 PM | Karyopharm Therapeutics (Issuer)
Shah Jatin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2021
5:47 PM | Frenkel Ran (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2021
5:46 PM | Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2021
5:45 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2021
5:44 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2021
2:12 PM | Consonance Capital Management LP (Filed by)
Karyopharm Therapeutics (Subject)
| Form SC 13G/A
| |
02/16/2021
1:21 PM | Consonance Capital Management LP (Filed by)
Karyopharm Therapeutics (Subject)
| Form SC 13G/A
| |
02/12/2021
7:13 AM | Avoro Capital Advisors LLC (Filed by)
Karyopharm Therapeutics (Subject)
| Form SC 13G/A
| |
02/11/2021
2:09 PM | Karyopharm Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G
| |
02/11/2021
7:19 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Karyopharm Therapeutics (Subject)
| Form SC 13G/A
| |
02/11/2021
6:13 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2021
8:56 PM | Karyopharm Therapeutics (Issuer)
Shah Jatin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2021
7:34 PM | Karyopharm Therapeutics (Issuer)
Lewis Tanya (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2021
7:33 PM | Frenkel Ran (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2021
7:32 PM | Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2021
7:30 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2021
7:28 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2021
7:06 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2021
6:39 PM | Karyopharm Therapeutics (Issuer)
Mitchener Stephen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/05/2021
6:33 PM | Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/22/2020
5:16 PM | Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2020
10:58 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2020
4:14 PM | Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2020
4:17 PM | Karyopharm Therapeutics (Issuer)
Primiano Christopher Brett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2020
6:05 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2020
3:17 PM | Karyopharm Therapeutics (Issuer)
Schor Chen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2020
3:12 PM | Karyopharm Therapeutics (Issuer)
Schor Chen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/04/2020
7:18 PM | Karyopharm Therapeutics (Issuer)
Lewis Tanya (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2020
7:16 PM | Karyopharm Therapeutics (Issuer)
Shah Jatin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2020
3:09 PM | Karyopharm Therapeutics (Issuer)
Primiano Christopher Brett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2020
3:23 PM | Karyopharm Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2020
3:11 PM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/14/2020
5:00 PM | Karyopharm Therapeutics (Issuer)
Primiano Christopher Brett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/14/2020
4:56 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/14/2020
4:54 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2020
8:22 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/31/2020
5:03 PM | Karyopharm Therapeutics (Issuer)
Oliger Christy J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/31/2020
4:44 PM | Karyopharm Therapeutics (Issuer)
Oliger Christy J. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/31/2020
3:36 PM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/18/2020
5:07 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2020
5:05 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2020
6:13 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2020
3:26 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2020
3:24 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2020
6:08 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/13/2020
5:45 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/13/2020
5:43 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2020
3:07 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2020
3:05 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2020
3:34 PM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2020
3:39 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2020
3:36 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2020
3:25 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2020
3:24 PM | Karyopharm Therapeutics (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2020
3:22 PM | Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2020
4:36 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2020
4:34 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2020
3:26 PM | Frenkel Ran (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2020
3:25 PM | Karyopharm Therapeutics (Issuer)
Primiano Christopher Brett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2020
3:22 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2020
4:05 PM | Karyopharm Therapeutics (Filer)
| Form 424B5
| |
05/05/2020
6:09 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2020
3:11 PM | Karyopharm Therapeutics (Filer)
| Form DEFA14A
| |
03/17/2020
4:35 PM | Greene Barry E (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2020
4:30 PM | DEMAREE JOHN (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2020
4:23 PM | DEMAREE JOHN (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/13/2020
3:17 PM | Karyopharm Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/11/2020
6:10 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2020
6:07 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/09/2020
4:11 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2020
7:33 PM | Karyopharm Therapeutics (Issuer)
Primiano Christopher Brett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2020
5:51 PM | Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2020
3:15 PM | Karyopharm Therapeutics (Filer)
| Form 424B5
| |
03/02/2020
6:05 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2020
6:39 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/28/2020
7:42 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2020
7:35 AM | Karyopharm Therapeutics (Filer)
| Form S-3ASR
| |
02/26/2020
6:17 AM | Karyopharm Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/21/2020
4:58 PM | Karyopharm Therapeutics (Issuer)
Shah Jatin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2020
4:57 PM | Frenkel Ran (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2020
4:55 PM | Karyopharm Therapeutics (Issuer)
Primiano Christopher Brett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2020
4:54 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2020
4:53 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
